AlphaStocks
2.3
Avoid

RadNet, Inc. (RDNT)

Health Care / Health Care Services

S&P SmallCap 600

$68.75

Scores poorly across most models. Proceed with caution.

Avoid

Score based on 4 of 5 models — moderate confidence

#1085out of 1121 in Health Care

Is RadNet, Inc. a Good Investment in 2026?

RadNet, Inc. (RDNT) scores 2.3 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model is the most favorable, rating RadNet, Inc. as Neutral. However, the Lynch model rates it Caution. RadNet, Inc. currently trades above its estimated fair value of $40, suggesting limited upside at current prices. RadNet, Inc. ranks #1085 out of 1121 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

ROE-1.7Market Cap5B

Estimated Fair Value

$39.8373% above

Trading above estimated fair value — the market may be pricing in future growth.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

3/9

Buffett

Caution

Business quality & competitive moat

Graham

Caution

Price vs intrinsic value

Lynch

Caution

Growth rate vs price (PEG)

Greenblatt

Neutral

Bottom half (rank 50%)

Frequently Asked Questions

Is RadNet, Inc. (RDNT) a good investment?
Based on AlphaStocks' composite analysis, RadNet, Inc. (RDNT) scores 2.3 out of 10, earning a Avoid rating. This score is below average, suggesting caution. Trading above estimated fair value — the market may be pricing in future growth.
What is RadNet, Inc.'s Piotroski F-Score?
RadNet, Inc.'s Piotroski F-Score status is Neutral. The raw score is 3/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is RDNT overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $40, RDNT appears overvalued. The stock currently trades 73% above its estimated fair value. Trading above estimated fair value — the market may be pricing in future growth.
How does RDNT compare to other Health Care stocks?
RadNet, Inc. ranks #1085 out of 1121 stocks in the Health Care sector, placing it in the top 97% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about RDNT?
AlphaStocks evaluates RDNT using five proven investment models. Piotroski: Neutral; Buffett: Caution; Graham: Caution; Lynch: Caution; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 2.3/10.

Similar Stocks

PARRBFAMAZN

Compare RDNT with

RDNT vs PARRRDNT vs BFAMRDNT vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer